Moberg Pharma (Sweden) Market Value

MOB Stock  SEK 17.85  0.42  2.41%   
Moberg Pharma's market value is the price at which a share of Moberg Pharma trades on a public exchange. It measures the collective expectations of Moberg Pharma AB investors about its performance. Moberg Pharma is selling for under 17.85 as of the 2nd of December 2024; that is 2.41% up since the beginning of the trading day. The stock's last reported lowest price was 17.3.
With this module, you can estimate the performance of a buy and hold strategy of Moberg Pharma AB and determine expected loss or profit from investing in Moberg Pharma over a given investment horizon. Check out Moberg Pharma Correlation, Moberg Pharma Volatility and Moberg Pharma Alpha and Beta module to complement your research on Moberg Pharma.
Symbol

Please note, there is a significant difference between Moberg Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moberg Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moberg Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Moberg Pharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Moberg Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Moberg Pharma.
0.00
12/13/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
12/02/2024
0.00
If you would invest  0.00  in Moberg Pharma on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Moberg Pharma AB or generate 0.0% return on investment in Moberg Pharma over 720 days. Moberg Pharma is related to or competes with Mendus AB, BioInvent International, Orexo AB, Oncopeptides, and Saniona AB. Moberg Pharma AB , a pharmaceutical company, develops and commercializes medical products for pain and skin conditions i... More

Moberg Pharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Moberg Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Moberg Pharma AB upside and downside potential and time the market with a certain degree of confidence.

Moberg Pharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Moberg Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Moberg Pharma's standard deviation. In reality, there are many statistical measures that can use Moberg Pharma historical prices to predict the future Moberg Pharma's volatility.
Hype
Prediction
LowEstimatedHigh
9.1017.8526.60
Details
Intrinsic
Valuation
LowRealHigh
6.8915.6424.39
Details
Naive
Forecast
LowNextHigh
6.0314.7823.53
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
11.6116.0420.47
Details

Moberg Pharma AB Backtested Returns

Moberg Pharma AB has Sharpe Ratio of -0.019, which conveys that the firm had a -0.019% return per unit of risk over the last 3 months. Moberg Pharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Moberg Pharma's Standard Deviation of 8.71, mean deviation of 4.28, and Risk Adjusted Performance of (0.02) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.0796, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Moberg Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Moberg Pharma is expected to be smaller as well. At this point, Moberg Pharma AB has a negative expected return of -0.17%. Please make sure to verify Moberg Pharma's potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if Moberg Pharma AB performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.13  

Insignificant reverse predictability

Moberg Pharma AB has insignificant reverse predictability. Overlapping area represents the amount of predictability between Moberg Pharma time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Moberg Pharma AB price movement. The serial correlation of -0.13 indicates that less than 13.0% of current Moberg Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient-0.13
Spearman Rank Test-0.16
Residual Average0.0
Price Variance79.65

Moberg Pharma AB lagged returns against current returns

Autocorrelation, which is Moberg Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Moberg Pharma's stock expected returns. We can calculate the autocorrelation of Moberg Pharma returns to help us make a trade decision. For example, suppose you find that Moberg Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Moberg Pharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Moberg Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Moberg Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Moberg Pharma stock over time.
   Current vs Lagged Prices   
       Timeline  

Moberg Pharma Lagged Returns

When evaluating Moberg Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Moberg Pharma stock have on its future price. Moberg Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Moberg Pharma autocorrelation shows the relationship between Moberg Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Moberg Pharma AB.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Moberg Stock Analysis

When running Moberg Pharma's price analysis, check to measure Moberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moberg Pharma is operating at the current time. Most of Moberg Pharma's value examination focuses on studying past and present price action to predict the probability of Moberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moberg Pharma's price. Additionally, you may evaluate how the addition of Moberg Pharma to your portfolios can decrease your overall portfolio volatility.